Apelin (gene name: Apln), an endogenous ligand that binds the G protein-coupled receptor angiotensin-like receptor 1 (APJ) [10], exhibits a therapeutic effect on central nervous system (CNS) disorders such as stroke, Alzheimer’s disease, and Moyamoya disease [11–13]. This evidence concerns the gene APLN and Alzheimer disease.